Apotek desmopressin nasal spray recalled over dislodged or missing cap liners
Apotek is recalling one lot of Desmopressin Nasal Spray, USP because of a defect in a batch of bottle caps involving dislodged or missing cap liners.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for a container closure defect with no fault described in the medicine itself, which fits the Moderate band for packaging problems.
Plain-English summary
Apotek Corp. is recalling Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, in 5 mL bottles providing 50 doses, NDC 60505-0815-0. The product is manufactured in Toronto, Ontario.
The stated reason is a defective container: a defect in a batch of bottle caps, specifically involving dislodged or missing cap liners. The FDA classified the action as Class II. The source does not describe any defect in the solution itself.
The affected lot is VM4231, expiry 06/30/2027. Distribution was USA nationwide.
This is a prescription medicine. Patients should not stop a prescribed treatment without medical advice; anyone holding the affected lot should contact their pharmacy or prescriber about a replacement supply.
The recalled product
- Product
- DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE)
- Brand
- DESMOPRESSIN ACETATE
- Manufacturer
- Apotex Corp.
- Category
- Drug — Nasal spray
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: VM4231
- Exp 06/30/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DESMOPRESSIN ACETATE
- HighFDA recalls prescription desmopressin acetate tablets for subpotency
FDA (Drugs) · 2022-12-07
Same manufacturer · Apotex Corp.
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- HighBrimonidine and timolol eye drops recalled over sterility assurance failure
FDA (Drugs) · 2026-03-25
- HighGlaucoma eye drops recalled over sterility assurance and bottle sealing concerns
FDA (Drugs) · 2025-10-08
- HighKetorolac ophthalmic solution recalled over sterility assurance and bottle sealing concerns
FDA (Drugs) · 2025-10-08
- SevereAzelastine Hydrochloride Ophthalmic Solution Recalled Due to Sterility
FDA (Drugs) · 2025-07-02
Same hazard · defective container
See all →- High
- ModeratePureLife benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModeratePearson Quality benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateBurkhart benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateDental City benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24